Mark Basil Swindells
Corporate Officer/Principal presso Exscientia AI Ltd.
Posizioni attive di Mark Basil Swindells
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Storia della carriera di Mark Basil Swindells
Precedenti posizioni note di Mark Basil Swindells
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EXSCIENTIA PLC | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
Posizioni
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Mark Basil Swindells
- Esperienza
